ARC
IART icon

Absolute Return Capital’s Integra LifeSciences IART Stock Holding History

Absolute Return Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,546
Closed -$184K – 763
2014
Q2 		$184K Buy
+9,546
New +$178K ﹤0.01% 1030

Other funds holding IART

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Absolute Return Capital's IART Position: Q3 2014 in Review

Absolute Return Capital sold out of Integra LifeSciences (IART) in Q3 2014, closing a stake of 9,546 shares — an estimated $184K sold.

Absolute Return Capital first reported a position in IART in Q2 2014 and held it in 1 quarter. The position peaked at $184K in Q2 2014. 143 funds tracked by Wall St. Rank hold IART as of Q3 2014.

  • Absolute Return Capital reported no remaining Integra LifeSciences position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 9,546 Integra LifeSciences shares in Q3 2014, an estimated $184K.
  • Absolute Return Capital first reported a position in Integra LifeSciences in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's Integra LifeSciences position peaked at $184K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.